click below
click below
Normal Size Small Size show me how
MCPHS-top200rx list
brand/generic
| brand | generic | Indications | Contraindications | class/category |
|---|---|---|---|---|
| Lorcet,Vicodin | Acetaminophen/Hydrocodone Bitartrate | Pain (Moderate to Severe) | hypersensitivity to acetaminophen/hydrocodone products | Analgesic Combination (Opioid) |
| Lipitor | Atorvastatin | Hyperlipidemia | hypersensitivity, liver disease, pregnancy or lactation | Antilipemic Agent, HMG-CoA Reductase Inhibitor |
| Synthroid/Levothroid/Unithroid/Levoxyl | Levothyroxine Sodium | Replacement or supplemental therapy in hypothyroidism; pituitary TSH suppression | Hypersensitivity,ecent MI or thyrotoxicosis; uncorrected adrenal insufficiency | Thyroid Product |
| Tenormin | Atenolol | Treatment of hypertension, alone or in combination with other agents; management of angina pectoris, postmyocardial infarction patients | Hypersensitivity,sinus bradycardia; sinus node dysfunction;cardiogenic shock; uncompensated cardiac failure; pulmonary edema; pregnancy;heart block greater than first-degree | Beta Blocker, Beta1 Selective |
| Amoxil | Amoxicillin | Treatment of otitis media, sinusitis, and infections caused by susceptible organisms involving the respiratory tract, skin, and urinary tract; prophylaxis of bacterial endocarditis in patients undergoing surgical or dental procedures | Hypersensitivity to amoxicillin, penicillin, or any component of the formulation | Antibiotic, Penicillin |
| Prinivil; Zestril | Lisinopril | Treatment of hypertension, either alone or in combination with other antihypertensive agents; adjunctive therapy in treatment of CHF (afterload reduction); treatment of acute myocardial infarction within 24 hours in hemodynamically-stable patients to impr | Hypersensitivity to lisinopril or any component of the formulation; angioedema related to previous treatment with an ACE inhibitor; bilateral renal artery stenosis; pregnancy (2nd and 3rd trimesters) | Angiotensin converting enzyme (ACE) inhibitors |
| HydroDIURIL | Hydrochlorothiazide-HCTZ | Management of mild to moderate hypertension; treatment of edema in congestive heart failure and nephrotic syndrome | Hypersensitivity to hydrochlorothiazide or any component of the formulation, thiazides, or sulfonamide-derived drugs; anuria; renal decompensation; pregnancy | Diuretics, thiazide and derivatives |
| Lasix | Furosemide | Management of edema associated with congestive heart failure and hepatic or renal disease; alone or in combination with antihypertensives in treatment of hypertension | Hypersensitivity to furosemide, any component, or sulfonylureas; anuria; patients with hepatic coma or in states of severe electrolyte depletion until the condition improves or is corrected | Diuretics, loop |
| Proventil;Ventolin | Albuterol Sulfate | Bronchodilator in reversible airway obstruction due to asthma or COPD; prevention of exercise-induced bronchospasm | Hypersensitivity to albuterol, adrenergic amines, or any component of the formulation | Adrenergic agonists; Bronchodilators |
| Xanax | Alprazolam | Treatment of anxiety disorder (GAD); panic disorder, with or without agoraphobia; anxiety associated with depression | Hypersensitivity to alprazolam or any component of the formulation (cross-sensitivity with other benzodiazepines may exist); narrow-angle glaucoma; concurrent use with ketoconazole or itraconazole; pregnancy | Anxiolytics; Benzodiazepines; Sedatives/hypnotics |
| Norvasc | Amlodipine | Treatment of hypertension; treatment of symptomatic chronic stable angina, vasospastic (Prinzmetal's) angina (confirmed or suspected); prevention of hospitalization due to angina with documented CAD (limited to patients without heart failure or ejection f | Hypersensitivity to amlodipine or any component of the formulation | Calcium channel blockers |
| Zoloft | Sertraline | Treatment of major depression; obsessive-compulsive disorder (OCD); panic disorder; post-traumatic stress disorder (PTSD); premenstrual dysphoric disorder (PMDD); social anxiety disorder | Hypersensitivity to sertraline or any component of the formulation; use of MAO inhibitors within 14 days; concurrent use of pimozide; concurrent use of sertraline oral concentrate with disulfiram | Antidepressant, Selective Serotonin Reuptake Inhibitor |
| Zithromax®; Zmax™;Z-PAK® | Azithromycin | Treatment of acute otitis media;treatment of mild-to-moderate upper and lower respiratory tract infections, infections of the skin and skin structure, community-acquired pneumonia, pelvic inflammatory disease (PID), sexually-transmitted diseases (urethrit | Hypersensitivity to azithromycin, other macrolide antibiotics, or any component of the formulation | Antibiotics, macrolides |
| Lopressor; Toprol XL | Metoprolol | Treatment of hypertension and angina pectoris; prevention of myocardial infarction, atrial fibrillation, flutter, symptomatic treatment of hypertrophic subaortic stenosis | Hypersensitivity to metoprolol or any component of the formulation; sick sinus syndrome; sinus bradycardia; heart block greater than first degree (except in patients with a functioning artificial pacemaker); cardiogenic shock; uncompensated cardiac failur | Beta Blocker, Beta1 Selective |
| Biocef; Keflex; Keftab | Cephalexin | Treatment of susceptible bacterial infections including respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections, including acute prostatitis; alternative therapy for acute bacteri | Hypersensitivity to cephalexin, any component of the formulation, or other cephalosporins | Antibiotics, cephalosporins(First Generation) |
| Darvocet A500; Darvocet N 100; Darvocet N 50; Propacet 100 | Propoxyphene and Acetaminophen | Management of mild to moderate pain | Hypersensitivity to propoxyphene, acetaminophen, or any component of the formulation | Analgesic Combination (Opioid) |
| Zocor | Simvastatin | Used with dietary therapy for the following:Secondary prevention of cardiovascular events in hypercholesterolemic patients with established coronary heart disease (CHD) or at high risk for CHD: To reduce cardiovascular morbidity (myocardial infarction, co | Hypersensitivity to simvastatin or any component of the formulation; acute liver disease; unexplained persistent elevations of serum transaminases; pregnancy; breast-feeding | Antilipemic Agent, HMG-CoA Reductase Inhibitor |
| Prevacid; Prevacid SoluTab | Lansoprazole | Oral: Short-term treatment of active duodenal ulcers; maintenance treatment of healed duodenal ulcers; as part of a multidrug regimen for H. pylori eradication to reduce the risk of duodenal ulcer recurrence; short-term treatment of active benign gastric | Hypersensitivity to lansoprazole, substituted benzimidazoles (ie, esomeprazole, omeprazole, pantoprazole, rabeprazole), or any component of the formulation | Proton Pump Inhibitor; Substituted Benzimidazole |
| Motrin | Ibuprofen | Oral: Inflammatory diseases and rheumatoid disorders including juvenile rheumatoid arthritis, mild-to-moderate pain, fever, dysmenorrhea | Hypersensitivity to ibuprofen, aspirin, other NSAIDs, or any component of the formulation; perioperative pain in the setting of coronary artery bypass surgery (CABG); pregnancy (3rd trimester | Nonsteroidal Anti-inflammatory Drug (NSAID), Oral; Nonsteroidal Anti-inflammatory Drug (NSAID), Parenteral |
| Dyazide; Maxzide; Maxzide-25 | Hydrochlorothiazide; Triamterene | Management of mild to moderate hypertension; treatment of edema in congestive heart failure and nephrotic syndrome | hydrochlorothiazide component: Hypersensitivity to hydrochlorothiazide or any component of the formulation, thiazides, or sulfonamide-derived drugs; anuria; renal decompensation; pregnancy. triamterene component: Hypersensitivity to triamterene or any com | Antihypertensive Agent Combination; Diuretic, Potassium Sparing; Diuretic, Thiazide |
| Premarin | Estrogens, Conjugated (1197) | Treatment of moderate-to-severe vasomotor symptoms associated with menopause; treatment of vulvar and vaginal atrophy; hypoestrogenism (due to hypogonadism, castration, or primary ovarian failure); prostatic cancer (palliation); breast cancer (palliation) | Hypersensitivity to estrogens or any component of the formulation; undiagnosed abnormal vaginal bleeding; history of or current thrombophlebitis or venous thromboembolic disorders (including DVT, PE); active or recent (within 1 year) arterial thromboembol | Estrogens; Hormones/hormone modifiers |
| Deltasone | Prednisone | Treatment of a variety of diseases including adrenocortical insufficiency, hypercalcemia, rheumatic, and collagen disorders; dermatologic, ocular, respiratory, gastrointestinal, and neoplastic diseases; organ transplantation and a variety of diseases incl | Hypersensitivity to prednisone or any component of the formulation; serious infections, except tuberculous meningitis; systemic fungal infections; varicella | Corticosteroid, Systemic |
| Glucophage | Metformin | Management of type 2 diabetes mellitus (noninsulin dependent, NIDDM) as monotherapy when hyperglycemia cannot be managed on diet alone. May be used concomitantly with a sulfonylurea or insulin to improve glycemic control. | Hypersensitivity to metformin or any component of the formulation; renal disease or renal dysfunction (serum creatinine ≥1.5 mg/dL in males or ≥1.4 mg/dL in females or abnormal creatinine clearance from any cause, including shock, acute myocardial infarct | Antidiabetic Agent, Biguanide |
| Ambien | Zolpidem Tartrate | Short-term treatment of insomnia (sleep onset and/or sleep maintenance) | Hypersensitivity to zolpidem or any component of the formulation | Hypnotic, Nonbenzodiazepine |
| Prozac | Fluoxetine | Treatment of major depressive disorder (MDD); treatment of binge-eating and vomiting in patients with moderate-to-severe bulimia nervosa; obsessive-compulsive disorder (OCD); premenstrual dysphoric disorder (PMDD); panic disorder with or without agoraphob | Hypersensitivity to fluoxetine or any component of the formulation; patients currently receiving MAO inhibitors, pimozide, or thioridazine; Note: MAO inhibitor therapy must be stopped for 14 days before fluoxetine is initiated. Treatment with MAO inhibito | Antidepressants, serotonin specific reuptake inhibitors |
| Allegra | Fexofenadine Hydrochloride | Relief of symptoms associated with seasonal allergic rhinitis; treatment of chronic idiopathic urticaria | Hypersensitivity to fexofenadine or any component of the formulation | Antihistamines, H1;Nonsedating |